Effectiveness and safety of tenofovir alafenamide for chronic hepatitis B patients
Not Applicable
Recruiting
- Conditions
- Chronic hepatitis B
- Registration Number
- JPRN-UMIN000029099
- Lead Sponsor
- Toranomon branch Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 650
Inclusion Criteria
Not provided
Exclusion Criteria
insufficient of clinical data
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Decline of HBsAg Seroclearance rate of HBsAg
- Secondary Outcome Measures
Name Time Method ormalized rate of ALT Undetectable rate of HBV DNA and HBeAg Changes of serum creatinine, eGFR, serum phosphate, urinary protein, urinary NAG, urinary beta-2-microglobrin, bone density